{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:12:12Z","timestamp":1783127532867,"version":"3.54.6"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ablation strategies for persistent atrial fibrillation (AF) remain controversial. Vein of Marshall ethanol infusion (VOM-EI) has been proposed to improve outcomes of catheter ablation for AF. This study aimed to evaluate the efficacy and safety of combining cryoballoon ablation (CBA) with VOM-EI in patients with persistent AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a single-center, real-world, non-randomized cohort study including consecutive patients with persistent AF who underwent CBA with or without VOM-EI between March 2021 and May 2024.Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were applied retrospectively to balance baseline characteristics between groups. The primary endpoint was freedom from atrial tachyarrhythmia at 12 months postablation. Safety outcomes included procedural complications and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After PSM, 47 patients in the CBA\u2009+\u2009VOM-EI group and 94 in the CBA-alone group were included in the analysis. At 12 months, freedom from atrial tachyarrhythmia was higher in the CBA combined with VOM-EI group (78.7%) compared with the CBA-alone group [57.4%; hazard ratio (HR): 0.42; 95% confidence interval (CI): 0.20\u20130.87;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.020] in the PSM cohort. A significantly lower risk of recurrent atrial tachyarrhythmia was also observed in the CBA combined with VOM-EI group in the IPTW-weighted cohort (HR: 0.38; 95% CI: 0.18\u20130.78;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.008). Procedural complication rates were similar between groups. Increased left atrial diameter (LAD) and longer AF duration were identified as risk factors of arrhythmia recurrence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CBA combined with VOM-EI is a feasible, effective, and safe strategy for treating persistent AF, with approximately 80% of patients remaining free from atrial arrhythmia recurrence at 1-year follow-up and a low incidence of complications. In addition, elevated LAD and longer AF duration were considered risk factors for atrial arrhythmia recurrence. These findings necessitate large-scale randomized controlled studies for further validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1685822","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:52:59Z","timestamp":1770879179000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of cryoballoon ablation combined with vein of Marshall ethanol infusion for persistent atrial fibrillation: a comparative cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Meixiang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Sha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbao","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University","place":["Taizhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tcm.2021.12.001","article-title":"Atrial fibrillation and stroke: a review and new insights","volume":"33","author":"Escudero-Martinez","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/europace\/euaa123","article-title":"Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V","volume":"22","author":"De With","year":"2020","journal-title":"Europace"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck","year":"2016","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.hrthm.2020.06.020","article-title":"Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: results from the multicenter STOP persistent AF trial","volume":"17","author":"Su","year":"2020","journal-title":"Heart Rhythm"},{"key":"B8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.hrthm.2015.10.023","article-title":"Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/europace\/euv067","article-title":"Prospective randomized comparison between a fixed \u20182C3L\u2019 approach vs. Stepwise approach for catheter ablation of persistent atrial fibrillation","volume":"17","author":"Dong","year":"2015","journal-title":"Europace"},{"key":"B10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jacep.2022.03.012","article-title":"Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: the STABLE-SR-II trial","volume":"8","author":"Yang","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.hrthm.2020.12.023","article-title":"Marshall bundle elimination, pulmonary vein isolation, and line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): prospective, single-center study","volume":"18","author":"Derval","year":"2021","journal-title":"Heart Rhythm"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4022\/jafib.2253","article-title":"Comparative study of cryoballoon versus radiofrequency for pulmonary vein isolation when combined with vein of Marshall ethanol infusion for paroxysmal atrial fibrillation","volume":"12","author":"Okishige","year":"2020","journal-title":"J Atr Fibrillation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/pace.12423","article-title":"Atrial tachycardias utilizing the ligament of Marshall region following single ring pulmonary vein isolation for atrial fibrillation","volume":"37","author":"Chik","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.hrthm.2009.08.034","article-title":"Ligament of Marshall: why it is important for atrial fibrillation ablation","volume":"6","author":"Hwang","year":"2009","journal-title":"Heart Rhythm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/europace\/euac219","article-title":"The adjunctive effect for left pulmonary vein isolation of vein of Marshall ethanol infusion in persistent atrial fibrillation","volume":"25","author":"Huang","year":"2023","journal-title":"Europace"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2020.16195","article-title":"Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial","volume":"324","author":"Valderrabano","year":"2020","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1161\/01.CIR.101.13.1503","article-title":"Vein of Marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation","volume":"101","author":"Hwang","year":"2000","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1253\/circj.CJ-21-0608","article-title":"Comparison of cryoballoon and contact force-sensing radiofrequency ablation for persistent atrial fibrillation in clinical practice","volume":"86","author":"Kobori","year":"2022","journal-title":"Circ J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/europace\/euab281","article-title":"Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)","volume":"24","author":"Shi","year":"2022","journal-title":"Europace"},{"key":"B21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jacc.2021.06.038","article-title":"Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review","volume":"78","author":"Andrade","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","article-title":"Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial","volume":"140","author":"Andrade","year":"2019","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1194687","DOI":"10.3389\/fcvm.2023.1194687","article-title":"A novel stepwise approach incorporating ethanol infusion in the vein of Marshall for the ablation of persistent atrial fibrillation","volume":"10","author":"Sousonis","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1276317","DOI":"10.3389\/fcvm.2023.1276317","article-title":"Efficacy and safety of the vein of Marshall ethanol infusion with radiofrequency catheter ablation for the treatment of persistent atrial fibrillation in elderly patients","volume":"10","author":"Luo","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/pace.14709","article-title":"A novel catheter ablation strategy for non-paroxysmal atrial fibrillation combining cryoballoon, radiofrequency, and Marshall-vein ethanol ablations","volume":"46","author":"Hayasaka","year":"2023","journal-title":"Pacing Clin Electrophysiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J Am Soc Echocardiogr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"euae204","DOI":"10.1093\/europace\/euae204","article-title":"Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)","volume":"26","author":"Goette","year":"2024","journal-title":"Europace"},{"key":"B29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10840-016-0131-8","article-title":"Changes in left ventricular filling parameters following catheter ablation of atrial fibrillation","volume":"47","author":"Krezowski","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e934569","DOI":"10.12659\/MSM.934569","article-title":"Predicting values of neutrophil-to-lymphocyte ratio (NLR), high-sensitivity C-reactive protein (hs-CRP), and left atrial diameter (LAD) in patients with nonvalvular atrial fibrillation recurrence after radiofrequency ablation","volume":"28","author":"Ding","year":"2022","journal-title":"Med Sci Monit"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1685822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:53:03Z","timestamp":1770879183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1685822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2026.1685822"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1685822","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1685822"}}